May 2 |
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
|
Apr 11 |
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Apr 3 |
Crinetics, Syndax gain amid pitch at Sohn charity conference (update)
|
Mar 26 |
Insider Sell: COO Jeff Knight Sells 32,359 Shares of Crinetics Pharmaceuticals Inc (CRNX)
|
Mar 22 |
Insider Sell: Chief Medical and Development Officer Dana Pizzuti Sells 15,089 Shares of ...
|
Mar 22 |
Director Matthew Fust Sells 60,000 Shares of Crinetics Pharmaceuticals Inc (CRNX)
|
Mar 21 |
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
|
Mar 21 |
Crinetics Pharmaceuticals Inc CFO Marc Wilson Sells 6,942 Shares
|
Mar 20 |
Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?
|
Mar 19 |
Crinetics Pharmaceuticals files to sell 8.33M shares of common stock for holders
|